Pro Nephro AKI (NGAL) is now FDA-Cleared     READ MORE

Mouse monoclonal antibody

Anti-GLP-1(9-37) and GLP-1(9-36)amide (N-terminal specific)

CAT NO: ABS 044-49 | Application: ELISA, WB


Cat. No.

ABS 044-49

Specificity

ABS 044-49 binds human GLP-1(9-36)amide. Based on inhibition ELISA, ABS 044-49 cross-reacts 3% with GLP-1(7-36)amide.

Immunogen

Synthetic GLP-1(9-18)

Host

Mouse

Positive Species Reactivity

Mammalia

Negative Species Reactivity

Not determined

Isotype

IgG1/k

Gene ID

2641

Clone Number

49

Epitope Specificity

The free N-terminus of GLP-1(9-36)amide and GLP-1(9-37).

Unit Size

400 µL: Cat. No. ABS 044-49-04 1 mL: Cat. No. ABS 044-49-1 1 mg/mL +/- 15%. See Certificate of Analysis for details.

Purification

Protein A/G purified (from culture supernatant)

Form

Liquid

Solvent

0.01 M phosphate buffer, pH 7.4, containing 0.5 M NaCl and 15 mM sodium azide

Conjugation

Unconjugated BSA free

Storage

4-8ºC without exposure to light. No precautions necessary during handling.

Target

Glucagon-like peptide-1(9-36)amide and GLP-1(9-37) are the forms of GLP-1 that result from the rapid degradation of the active forms of the peptide (GLP-1(7-36)amide and GLP-1(7-37)) by the enzyme dipeptidyl peptidase-IV (DPP-IV, also known as CD26 or adenosine deaminase binding protein). GLP-1 is a peptide hormone of the glucagon family, produced by the L cells of the intestinal mucosa from the same prohormone as glucagon. The active forms are potent stimulators of glucose-dependent insulin secretion. The sequence of GLP-1 is fully conserved in all mammalian species examined so far.